Recursion Pharmaceuticals Inc (RXRX)

Jan 07, 2026

Recursion Pharmaceuticals (RXRX) Climbs 6.8% Ahead of Next Week's Business Updates - Finviz

Jan 07, 2026

Jan 07, 2026

Recursion pharma director Gibson sells $170k in shares By Investing.com - Investing.com India

Jan 07, 2026

Jan 07, 2026

Recursion’s Stock Surge: An Opportunity? - StocksToTrade

Jan 07, 2026

Jan 07, 2026

Recursion Pharmaceuticals (RXRX) Climbs 6.8% Ahead of Next Week’s Business Updates - Insider Monkey

Jan 07, 2026

Jan 07, 2026

RXRX Stock’s Impressive Surge: A Closer Look - timothysykes.com

Jan 07, 2026

Jan 07, 2026

Why Recursion Pharmaceuticals (RXRX) Is Up 10.7% After Positive REC-4881 Trial Data And Rising Analyst Focus - simplywall.st

Jan 07, 2026

Jan 06, 2026

Recursion Pharmaceuticals Inc Stock Analysis and ForecastLow Risk Investment Ideas & AI-Based Insights for Consistent Profits - earlytimes.in

Jan 06, 2026

Jan 06, 2026

Recursion Pharmaceuticals, Inc. (RXRX) Investor Outlook: Uncovering a 60% Upside Potential in Biotech Innovation - DirectorsTalk Interviews

Jan 06, 2026

Jan 06, 2026

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. - AOL.com

Jan 06, 2026

Jan 06, 2026

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance Singapore

Jan 06, 2026

Jan 06, 2026

Is Recursion Pharmaceuticals (RXRX) Mispriced After Volatile Share Performance And Ongoing Tech Partnerships - simplywall.st

Jan 06, 2026

Jan 04, 2026

Recursion Pharmaceuticals (RXRX): Assessing Valuation After New Activist Investor Filings With the SEC - simplywall.st

Jan 04, 2026

Jan 04, 2026

JPMorgan boosts rating on Recursion Pharmaceuticals (RXRX) amid AI-driven drug pipeline - MSN

Jan 04, 2026

Jan 04, 2026

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript - MSN

Jan 04, 2026

Jan 02, 2026

Recursion Pharmaceuticals Stock (RXRX) Opinions on Analyst Upgrade and Insider Trading - Quiver Quantitative

Jan 02, 2026

Jan 02, 2026

Here’s What J.P. Morgan Thinks About Recursion Pharmaceuticals (RXRX) - Insider Monkey

Jan 02, 2026

Jan 02, 2026

JPMorgan Boosts Rating on Recursion Pharmaceuticals (RXRX) Amid AI-Driven Drug Pipeline - Insider Monkey

Jan 02, 2026

Jan 02, 2026

Bank Pictet & Cie Europe AG Acquires Shares of 1,630,000 Recursion Pharmaceuticals, Inc. $RXRX - MarketBeat

Jan 02, 2026

Jan 01, 2026

Recursion Pharmaceuticals reports positive Phase 1b/2 TUPELO trial results, validating AI-driven therapy for FAP - MSN

Jan 01, 2026

Dec 30, 2025

Cathie Wood’s ARK Investment buys 755K shares of Recursion Pharmaceuticals, Inc. (RXRX) - MSN

Dec 30, 2025

Dec 30, 2025

Cathie Wood’s ARK Investment Buys 755K Shares Of Recursion Pharmaceuticals, Inc. (RXRX) - Yahoo Finance

Dec 30, 2025

Dec 30, 2025

Cathie Wood's ARK Investment Buys 755K Shares Of Recursion Pharmaceuticals, Inc. (RXRX) - Finviz

Dec 30, 2025

Dec 30, 2025

Recursion Pharmaceuticals (NASDAQ:RXRX) CFO Ben Taylor Sells 21,383 Shares - MarketBeat

Dec 30, 2025

Dec 30, 2025

Taylor, CFO of Recursion Pharmaceuticals, sells $89k in shares By Investing.com - Investing.com UK

Dec 30, 2025

Dec 30, 2025

Taylor, CFO of Recursion Pharmaceuticals, sells $89k in shares - Investing.com

Dec 30, 2025

Dec 30, 2025

RXRX Stock Today: Insider Selling, CEO Transition and Trial Catalyst Shape Recursion Pharmaceuticals’ Outlook (December 2025) - ts2.tech

Dec 30, 2025

Dec 30, 2025

Top Biotech Stocks To ResearchDecember 17th - MarketBeat

Dec 30, 2025

Dec 29, 2025

Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Najat Khan Sells 124,403 Shares - MarketBeat

Dec 29, 2025

Dec 29, 2025

Recursion Pharmaceuticals Executive Sells Shares - TradingView — Track All Markets

Dec 29, 2025

Dec 29, 2025

RXRX Stock Plummet: Here’s What’s Happening - timothysykes.com

Dec 29, 2025

Dec 29, 2025

Recursion Pharmaceuticals Reports Positive Phase 1b/2 TUPELO Trial Results, Validating AI-Driven Therapy for FAP - Insider Monkey

Dec 29, 2025

Dec 28, 2025

Best Biotech Stocks To Follow NowDecember 26th - MarketBeat

Dec 28, 2025

Dec 28, 2025

10 AI Stocks Under $20 to Buy Now - Insider Monkey

Dec 28, 2025

Dec 28, 2025

Recursion Pharmaceuticals Rises as Positive Phase 1b/2 Trial Results for REC-4881 Validate AI-Driven Drug Discovery Platform - Finviz

Dec 28, 2025

Dec 28, 2025

Cathie Wood is doubling down on Recursion Pharmaceuticals stock. Should you buy RXRX here? - MSN

Dec 28, 2025

Dec 28, 2025

Recursion Pharmaceuticals Stock (RXRX) Opinions on Analyst Upgrade and Clinical Data - Quiver Quantitative

Dec 28, 2025

Dec 26, 2025

Growth or Bubble? Decoding Recursion Pharmaceuticals’ Stock Surge - timothysykes.com

Dec 26, 2025

Dec 26, 2025

3 Small AI Plays to Buy for 2026 - Sahm

Dec 26, 2025

Dec 26, 2025

Is Recursion Pharmaceuticals, Inc. (RXRX) the best fundamentally strong penny stock to buy? - MSN

Dec 26, 2025

Dec 25, 2025

Is Recursion (RXRX) Finally Proving Its AI Drug Discovery Model With REC-4881’s Early Data? - simplywall.st

Dec 25, 2025

Dec 24, 2025

Recursion Pharmaceuticals (RXRX) Stock News Today: Analysts Refocus on REC-4881 Data, ARK Buying, and a 2026 CEO Transition - ts2.tech

Dec 24, 2025

Dec 24, 2025

Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here? - Barchart.com

Dec 24, 2025